Citadel Advisors’s Prenetics Global PRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$309K Buy
+16,187
New +$299K ﹤0.01% 11049
2023
Q1
Sell
-733
Closed -$22K 15314
2022
Q4
$22K Buy
+733
New +$29.7K ﹤0.01% 13068
2022
Q3
Sell
-783
Closed -$47K 13376
2022
Q2
$47K Buy
+783
New +$55.9K ﹤0.01% 11972

Other funds holding PRE

Citadel Advisors's PRE Position: Q2 2026 in Review

Citadel Advisors opened a new position in Prenetics Global (PRE) in Q2 2026: 16,187 shares worth $309K. The stake represents ﹤0.01% of the portfolio and ranks #11049 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in PRE as recently as Q4 2022.

Citadel Advisors first reported a position in PRE in Q2 2022 and has held it in 3 quarters since. 25 funds tracked by Wall St. Rank hold PRE as of Q2 2026.

  • Citadel Advisors held 16,187 shares of Prenetics Global worth $309K as of Q2 2026.
  • Prenetics Global was a new Citadel Advisors position in Q2 2026.
  • Prenetics Global made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11049 holding.
  • Citadel Advisors first reported a position in Prenetics Global in Q2 2022 and has held it in 3 quarters since.
  • 25 funds tracked by Wall St. Rank held Prenetics Global as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.